GENELABS TECHNOLOGIES INC /CA
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: GENELABS TECHNOLOGIES INC /CA, 10-Q, 2000-11-14
Next: UNION NATIONAL FINANCIAL CORP / PA, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           6,728
<SECURITIES>                                       470
<RECEIVABLES>                                      216
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 7,414
<PP&E>                                          10,575
<DEPRECIATION>                                   9,014
<TOTAL-ASSETS>                                   9,988
<CURRENT-LIABILITIES>                            3,447
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       158,424
<OTHER-SE>                                   (152,384)
<TOTAL-LIABILITY-AND-EQUITY>                     9,988
<SALES>                                              0
<TOTAL-REVENUES>                                 5,205
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                14,759
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (206)
<INCOME-PRETAX>                                (9,348)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (9,348)
<DISCONTINUED>                                     282
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (9,066)
<EPS-BASIC>                                     (0.21)
<EPS-DILUTED>                                   (0.21)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission